Attached files
file | filename |
---|---|
8-K - FORM 8-K - MONSANTO CO /NEW/ | y92965e8vk.htm |
Exhibit 99
Monsanto Company
800 North Lindbergh Blvd
St. Louis, Missouri 63167
800 North Lindbergh Blvd
St. Louis, Missouri 63167
Release
|
Immediately | |||
Contact
|
Media: | Kelli Powers (314-694-4003) | ||
Analysts: | Bryan Hurley (314-694-8148) |
SEEDS-AND-TRAITS MOMENTUM DRIVES MONSANTO FISCAL-YEAR 2011 EARNINGS GROWTH; FISCAL-YEAR 2012
POSITIONED FOR MID-TEENS EARNINGS GROWTH ON NEW BASE
| Cash flow, earnings per share and gross profit above estimates as new corn, soybean platforms lead U.S. improvement; Latin America helps drive 2012 guidance for EPS of $3.34 to $3.44 | ||
| Company to restate financial results for 2009, 2010, and prior 2011 quarters to reflect timing of accruals for customer incentives in glyphosate business |
o | Total revenues and costs over the three fiscal years as a whole remain unchanged | ||
o | Full-year 2011 EPS benefits by $0.05 |
ST. LOUIS (Oct. 5, 2011) Monsanto Company (NYSE: MON) generated fiscal fourth quarter and
full-year results above guidance, executives said today, noting the company is well-positioned to
realize its mid-teens earnings growth opportunity off its higher base next year. Executives said
the company gained improvement in its core U.S. business on the strength of new corn and soybean
products and captured global growth opportunities, most notably in Latin America, that have
reignited momentum for future growth.
Fourth Quarter | Fiscal Year | |||||||
($ in millions) | 2011 | 2011 | ||||||
Net Sales By Segment |
||||||||
Corn seed and traits |
$ | 671 | $ | 4,805 | ||||
Soybean seed and traits |
96 | 1,542 | ||||||
Cotton seeds and traits |
181 | 847 | ||||||
Vegetable seeds |
267 | 895 | ||||||
All other crops seeds and traits |
136 | 493 | ||||||
TOTAL Seeds and Genomics |
$ | 1,351 | $ | 8,582 | ||||
Agricultural productivity |
$ | 896 | $ | 3,240 | ||||
TOTAL Agricultural Productivity |
$ | 896 | $ | 3,240 | ||||
TOTAL Net Sales |
$ | 2,247 | $ | 11,822 | ||||
Gross Profit |
$ | 971 | $ | 6,079 | ||||
Operating Expenses |
$ | 1,042 | $ | 3,577 | ||||
Interest Expense Net |
$ | 21 | $ | 88 | ||||
Other Expense Net |
$ | 2 | $ | 40 | ||||
Net Income (Loss) Attributable to Monsanto Company |
$ | (112 | ) | $ | 1,607 | |||
Diluted Earnings (Loss) per Share (See note 1.) |
$ | (0.21 | ) | $ | 2.96 | |||
Items Affecting Comparability EPS Impact |
||||||||
Restructuring charges |
(0.01 | ) | | |||||
Diluted Earnings (Loss) per Share from Ongoing Business |
||||||||
(For the definition of ongoing EPS, see note 1.) |
$ | (0.22 | ) | $ | 2.96 | |||
Effective Tax Rate |
3 | % | 30 | % |
Fourth Quarter | Fiscal Year | |||||||
2011 | 2011 | |||||||
Comparison as a Percent of Net Sales: | ||||||||
Gross profit |
43 | % | 51 | % | ||||
Selling, general and administrative expenses (SG&A) |
29 | % | 19 | % | ||||
Research and development expenses |
18 | % | 12 | % | ||||
Income (Loss) from continuing operations before income taxes |
(4 | )% | 20 | % | ||||
Net income (Loss) attributable to Monsanto Company |
(5 | )% | 14 | % |
Comment from Monsanto Chairman, President and Chief Executive Officer Hugh Grant:
As we bring this year to a very successful close and look at whats to come, its clear that we
have turned a corner and returned to growth mode. We made a conscious effort to reconnect with our
customers, and from that earned significant sales growth for seeds and traits and created positive
momentum we carry into 2012. Through the combination of advanced product platforms, a more
balanced business and increasingly global opportunities, I believe we have the essential elements
in place to achieve mid-teens growth in fiscal year 2012.
Results of Operations
Monsanto reported net sales of $2.2 billion for the fourth quarter of fiscal year 2011. Net sales
for the fiscal year were $11.8 billion.
Seeds and Genomics net sales were $1.4 billion for the quarter, a 39 percent increase over the
prior year. For the year, sales for the Seeds and Genomics segment reached $8.6 billion, a 13
percent increase over the prior year driven by strong global growth in corn and cotton. Latin
America continues to be a significant driver for the Seeds and Genomics segment, demonstrating
momentum and continued growth potential.
Agricultural Productivity net sales were $896 million for the quarter, in line with the companys
expectations. Net sales for the Agricultural Productivity segment for the year grew to $3.2
billion.
Monsanto reported a net loss of $112 million in the fourth quarter of fiscal year 2011. Net income
for fiscal year 2011 was $1.6 billion.
The companys fiscal year 2011 earnings per share (EPS) were $2.96 on an ongoing basis and an
as-reported basis. For the fourth quarter, the company reported a loss per share of $(0.22) on an
ongoing basis and $(0.21) on an as-reported basis. As-reported EPS results for the fourth quarter
and fiscal year 2011 reflect the effects of restructuring and discontinued operations. (For a
reconciliation of ongoing EPS, see page 1 and note 1.)
Financial Reporting Update
The company provided an update on the previously announced SEC investigation into the financial
reporting of its customer incentive programs related to glyphosate products in fiscal years 2009
and 2010. The Company continues to cooperate with the SEC.
Following the SEC notification, Monsanto began its own review and the Audit and Finance Committee
of its Board of Directors retained independent advisors to conduct an internal investigation.
Based on the results of that work, Monsanto will adjust portions of its financial statements
related to the timing of the accounting for customer incentive programs for glyphosate products
from the fourth quarter of fiscal year 2009 through the third quarter of fiscal year 2011, and
correct its previously issued financial statements for this period to reflect these adjustments.
Total company revenues and costs for these fiscal years, taken as a whole, are unchanged, but the timing of
those amounts will change. The potential impact of these changes would affect fiscal year 2009
earnings per share by approximately ($0.10) to ($0.05) and affect earnings per share for fiscal
year 2010 by approximately ($0.02) to $0.03. The fiscal year 2011 earnings per share of $2.96
includes $0.05 of incremental benefit from the accounting adjustment.
The adjustments do not affect any financial information for the Seeds and Genomics segment, and the
fiscal year 2011 financial information reported today includes all adjustments Monsanto is making
to that full fiscal year. As a result of the adjustments to prior financial statements, the
company is not providing comparisons with prior financial periods in this earnings release, except
for the Seeds and Genomics segment. All adjustments will be reflected in Monsantos Form 10-K
filing later this month.
Cash Flow
For fiscal year 2011, net cash provided by operating activities was $2.8 billion. Net cash
required by investing activities was $975 million in fiscal year 2011. Net cash required by
financing activities was $864 million for fiscal year 2011. As a result, free cash flow was a
source of $1.8 billion for fiscal year 2011. (For a reconciliation of free cash flow, see note 1.)
Outlook
In fiscal year 2012, Monsanto expects to achieve mid teens earnings growth off the 2011 EPS base
for a range of $3.34 to $3.44 EPS. (For a reconciliation of 2012 EPS guidance, see note 1.) The
company noted that as the business in Latin America continues to ascend, it views 2012 as the first
year of some structural changes to its historical earnings pattern. The first quarter, still a
small quarter, is expected to see more contribution from the growth in Brazil and Argentina that
would yield first-quarter ongoing and as-reported earnings per share in the range of $0.10 to $0.15
per share.
The Seeds and Genomics segment, which saw significant gross profit increase in 2011 and represents
the growth area for Monsantos business in fiscal year 2012 and beyond, is expected to deliver both
single digit percentage unit volume growth and continued mix improvement. The company expects
Seeds and Genomics gross profit in the range of $5.7 billion to $5.85 billion for the year, with
unit volume growth complemented by mix from both germplasm and trait upgrades globally.
Gross profit for the Agricultural Productivity segment is expected at roughly $800 million.
The company projects free cash flow in the range of $1.3 billion to $1.5 billion for fiscal year
2012. The company expects net cash provided by operating activities to be $2.2 billion to $2.5
billion, and net cash required by investing activities to be approximately $900 million to $1
billion for fiscal year 2012. (For a reconciliation of free cash flow, see note 1.)
In fiscal 2012, the company expects selling, general and administrative expenses to be in the range
of $2.25 billion to $2.35 billion, reflecting inflationary level increases. On a percent of sales
basis, the company has reduced its SG&A spend rate over the past several years, and the 2012 range
maintains that trend. The companys research and development spend is projected at $1.4 billion to
$1.45 billion.
Seeds and Genomics Segment Detail
Net Sales | Gross Profit | |||||||||||||||||||||||||||||||
Fourth Quarter | Fiscal Year | Fourth Quarter | Fiscal Year | |||||||||||||||||||||||||||||
($ in millions) | 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | 2011 | 2010 | ||||||||||||||||||||||||
Seeds and Genomics | ||||||||||||||||||||||||||||||||
Corn Seed and Traits |
$ | 671 | $ | 424 | $ | 4,805 | $ | 4,260 | $ | 340 | $ | 170 | $ | 2,864 | $ | 2,464 | ||||||||||||||||
Soybean Seed and Traits |
96 | 103 | 1,542 | 1,486 | 92 | 88 | 1,045 | 905 | ||||||||||||||||||||||||
Cotton Seed and Traits |
181 | 98 | 847 | 611 | 140 | 78 | 642 | 454 | ||||||||||||||||||||||||
Vegetable Seeds |
267 | 235 | 895 | 835 | 173 | 130 | 534 | 492 | ||||||||||||||||||||||||
All Other Crops Seeds
and Traits |
136 | 110 | 493 | 419 | 45 | 57 | 221 | 223 | ||||||||||||||||||||||||
TOTAL Seeds and Genomics |
$ | 1,351 | $ | 970 | $ | 8,582 | $ | 7,611 | $ | 790 | $ | 523 | $ | 5,306 | $ | 4,538 | ||||||||||||||||
Earnings (Loss) Before Interest & Taxes (EBIT) | ||||||||||||||||
Fourth Quarter | Fiscal Year | |||||||||||||||
($ in millions) | 2011 | 2010 | 2011 | 2010 | ||||||||||||
Seeds and Genomics | ||||||||||||||||
EBIT (For a reconciliation of EBIT, see note 1.) |
$ | (157 | ) | $ | (412 | ) | $ | 2,106 | $ | 1,597 | ||||||
Unusual Items Affecting EBIT: Restructuring |
$ | 4 | $ | (102 | ) | $ | (11 | ) | $ | (232 | ) |
The Seeds and Genomics segment consists of the companys global seeds and related traits
business.
It was a significant quarter for the segment, with sales of $1.4 billion representing an increase
of 39 percent over the same period last year. This growth was led by a strong contribution from
Latin America and gross profit increases in each of the companys core crops corn, cotton and
soybeans as well as vegetables at a global level. For the year, segment sales reached $8.6
billion, reflecting a 13 percent increase over the prior year.
Corn led the segment for the year, driven by growth in South America, with additional improvements
in the United States and Europe. In the United States, branded corn volume grew by the largest
increment in three years and outpaced the market expansion. The company earned a 10-million acre
increase to reach 13 million planted U.S. acres for its Genuity® Reduced Refuge Family,
which includes Genuity® SmartStax®, Genuity® VT Triple
PRO® and Genuity® VT Double PRO®. In 2012, the company has a goal
to earn 22 million to 24 million acres for the Reduced Refuge Family. For Genuity®
SmartStax®, the company will offer more than 100 hybrids across all channels in 2012,
when all of Monsantos branded SmartStax® will be sold as RIB Complete. SmartStax is the
industrys only 5 percent single-bag refuge-in-the-bag product offering above ground and below
ground protection. The company also sees expansion opportunities for Genuity® VT Triple
PRO® and Genuity® VT Double PRO®, which will shift from trial
levels to broad availability in major geographies for 2012. Following regulatory approval, the
company also expects Genuity® VT Double PRO® volume to move to RIB
CompleteTM as well.
In 2012, the company views Latin America as the largest source of new growth complementing the U.S.
business, driven by the ramp up of the corn opportunity in Brazil and Argentina. In Argentina, the
company expects total corn acres to expand to the high end of the historical acre base and looks to
accelerate the conversion of double-stacks to Genuity® Triple PRO®, which
brings new insect protection and value to farmers. In Brazil, Monsanto is already the industry
leader and looks forward to ramping up overall trait penetration and upgrade from first-generation
products to higher-value second-generation traits.
Cotton revenue also increased as a function of increased acres in Australia and the United States.
The company saw a resurgence in its Deltapine brand in the United States as breeding improvements
help earn the farmers business, resulting in volume and share improvements.
In soybeans, the company earned a total of 17 million U.S. acres for its Genuity®
Roundup Ready 2 Yield® product in 2011, a 10-million-acre step up over the prior year.
The company expects Roundup Ready 2 Yield® to reach more than 27 million to 30 million
acres in 2012 and serve as the leading product in Monsantos brands.
Agricultural Productivity Segment Detail
($ in millions) | Net Sales | Gross Profit | ||||||||||||||
Fourth Quarter | Fiscal Year | Fourth Quarter | Fiscal Year | |||||||||||||
TOTAL Agricultural Productivity |
$ | 896 | $ | 3,240 | $ | 181 | $ | 773 |
($ in millions) | Earnings (Loss) Before Interest & Taxes (EBIT) | |||||||
Agricultural Productivity | 2011 | |||||||
Fourth Quarter | Fiscal Year | |||||||
EBIT (For a reconciliation of EBIT, see note 1.) |
$ | 59 | $ | 281 | ||||
Unusual Items Affecting EBIT: |
||||||||
EBIT from Discontinued Operations |
$ | (1 | ) | $ | 3 | |||
Restructuring |
$ | 4 | $ | 8 |
The Agricultural Productivity segment consists of the crop protection products and
lawn-and-garden herbicide products. Segment sales for the quarter reached $896 million, with gross
profit of $181 million. For the year, the segment delivered net sales of $3.2 billion with gross
profit of $773 million.
Webcast Information
In conjunction with this announcement, Monsanto will hold a conference call at 8:30 a.m. central
time (9:30 a.m. eastern time) today. The call will focus on these results and future expectations
and may include a discussion of Monsantos strategic initiatives, product performance and other
matters related to the companys business.
Presentation slides and a simultaneous audio webcast of the conference call may be accessed by
visiting the companys web site at www.monsanto.com and clicking on Investor Information.
Visitors may need to download Windows Media Player prior to listening to the webcast. Following
the live broadcast, a replay of the webcast will be available on the Monsanto Web site for three
weeks.
About Monsanto Company
Monsanto Company is a leading global provider of technology-based solutions and agricultural
products that improve farm productivity and food quality. Monsanto remains focused on enabling both
small-holder and large-scale farmers to produce more from their land while conserving more of our
worlds natural resources such as water and energy. To learn more about our business and our
commitments, please visit: www.monsanto.com. Follow our business on Twitter® at
www.twitter.com/MonsantoCo, on the company blog, Beyond the Rows® at
www.monsantoblog.com, or subscribe to our News Release RSS Feed.
Cautionary Statements Regarding Forward-Looking Information:
Certain statements contained in this release are forward-looking statements, such as statements
concerning the companys anticipated financial results, current and future product performance,
regulatory approvals, business and financial plans and other non-historical facts. These statements
are based on current expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties, the companys actual
performance and results may differ materially from those described or implied by such
forward-looking statements. Factors that could cause or contribute to such differences include,
among others: continued competition in seeds, traits and agricultural chemicals; the companys
exposure to various contingencies, including those related to intellectual property protection,
regulatory compliance and the speed with which approvals are received, and public acceptance of
biotechnology products; the success of the companys research and development activities; the
outcomes of major lawsuits and the previously-announced SEC investigation; developments related to
foreign currencies and economies; successful operation of recent acquisitions; fluctuations in
commodity prices; compliance with regulations affecting our manufacturing; the accuracy of the
companys estimates related to distribution inventory levels; the companys ability to fund its
short-term financing needs and to obtain payment for the products that it sells; the effect of
weather conditions, natural disasters and accidents on the agriculture business or the companys
facilities; and other risks and factors detailed in the companys most recent Form 10-K Report to
the SEC. Undue reliance should not be placed on these forward-looking statements, which are current
only as of the date of this release. The company disclaims any current intention or obligation to
update any forward-looking statements or any of the factors that may affect actual results.
Notes to editors: Genuity, SmartStax, RIB Complete, VT Triple PRO, VT Double PRO and Roundup Ready
2 Yield are trademarks of Monsanto Company and its wholly-owned subsidiaries.
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Statements of Consolidated Operations
Three Months Ended | Twelve Months Ended | |||||||
Aug. 31, | Aug. 31, | |||||||
2011 | 2011 | |||||||
Net Sales |
$ | 2,247 | $ | 11,822 | ||||
Cost of Goods Sold |
1,276 | 5,743 | ||||||
Gross Profit |
971 | 6,079 | ||||||
Operating Expenses: |
||||||||
Selling, general and administrative expenses |
647 | 2,190 | ||||||
Research and development expenses |
404 | 1,386 | ||||||
Restructuring charges, net |
(9 | ) | 1 | |||||
Total Operating Expenses |
1,042 | 3,577 | ||||||
Income (Loss) From Operations |
(71 | ) | 2,502 | |||||
Interest Expense |
45 | 162 | ||||||
Interest Income |
(24 | ) | (74 | ) | ||||
Other Expense, Net |
2 | 40 | ||||||
Income (Loss) from Continuing Operations Before Income Taxes |
(94 | ) | 2,374 | |||||
Income Tax Provision |
3 | 717 | ||||||
Income (Loss) from Continuing Operations Including Portion
Attributable to Noncontrolling Interest |
$ | (97 | ) | $ | 1,657 | |||
Discontinued Operations: |
||||||||
Income (Loss) from Operations of Discontinued Businesses |
(1 | ) | 3 | |||||
Income Tax Provision |
| 1 | ||||||
Income (Loss) on Discontinued Operations |
(1 | ) | 2 | |||||
Net Income (Loss) |
$ | (98 | ) | $ | 1,659 | |||
Less: Net Income Attributable to Noncontrolling Interest |
14 | 52 | ||||||
Net Income (Loss) Attributable to Monsanto Company |
$ | (112 | ) | $ | 1,607 | |||
EBIT (see note 1) |
$ | (98 | ) | $ | 2,387 | |||
Basic Earnings (Loss) per Share Attributable to Monsanto Company: |
||||||||
Income (Loss) from Continuing Operations |
$ | (0.21 | ) | $ | 2.99 | |||
Income on Discontinued Operations |
| 0.01 | ||||||
Net Income (Loss) Attributable to Monsanto Company |
$ | (0.21 | ) | $ | 3.00 | |||
Diluted Earnings (Loss) per Share Attributable to Monsanto Company: |
||||||||
Income (Loss) from Continuing Operations |
$ | (0.21 | ) | $ | 2.96 | |||
Net Income (Loss) Attributable to Monsanto Company |
$ | (0.21 | ) | $ | 2.96 | |||
Weighted Average Shares Outstanding: |
||||||||
Basic |
535.1 | 536.5 | ||||||
Diluted |
535.1 | 542.4 |
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Condensed Statements of Consolidated Financial Position
As of | ||||
Aug. 31, 2011 | ||||
Assets |
||||
Current Assets: |
||||
Cash and cash equivalents (variable interest entities restricted - 2011: $96) |
$ | 2,572 | ||
Short-term investments |
302 | |||
Trade receivables, net (variable interest entities restricted - 2011: $51) |
2,117 | |||
Miscellaneous receivables |
629 | |||
Deferred tax assets |
446 | |||
Inventory, net |
2,623 | |||
Other current assets |
152 | |||
Total Current Assets |
8,841 | |||
Property, Plant and Equipment, Net |
4,394 | |||
Goodwill |
3,365 | |||
Other Intangible Assets, Net |
1,309 | |||
Noncurrent Deferred Tax Assets |
873 | |||
Long-Term Receivables, Net |
475 | |||
Other Assets |
619 | |||
Total Assets |
$ | 19,876 | ||
Liabilities and Shareowners Equity |
||||
Current Liabilities: |
||||
Short-term debt, including current portion of long-term debt |
678 | |||
Accounts payable |
871 | |||
Income taxes payable |
117 | |||
Accrued compensation and benefits |
427 | |||
Accrued marketing programs |
1,110 | |||
Deferred revenues |
373 | |||
Grower production accruals |
87 | |||
Dividends payable |
161 | |||
Customer payable |
94 | |||
Restructuring reserves |
24 | |||
Miscellaneous short-term accruals |
819 | |||
Total Current Liabilities |
4,761 | |||
Long-Term Debt |
1,543 | |||
Postretirement Liabilities |
509 | |||
Long-Term Deferred Revenue |
337 | |||
Noncurrent Deferred Tax Liabilities |
152 | |||
Long-Term Portion of Environmental and Litigation Reserves |
176 | |||
Other Liabilities |
682 | |||
Monsanto Shareowners Equity |
11,545 | |||
Noncontrolling Interest |
171 | |||
Total Shareowners Equity |
11,716 | |||
Total Liabilities and Shareowners Equity |
$ | 19,876 | ||
Debt to Capital Ratio: |
16 | % |
Monsanto Company
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Selected Financial Information
(Dollars in millions, except per share amounts)
Unaudited
Statements of Consolidated Cash Flows
Twelve Months Ended Aug. 31, 2011 | ||||
Operating Activities: |
||||
Net Income |
$ | 1,659 | ||
Adjustments to reconcile cash provided (required) by operating activities: |
||||
Items that did not require (provide) cash: |
||||
Depreciation and amortization |
613 | |||
Bad-debt expense |
3 | |||
Stock-based compensation expense |
104 | |||
Excess tax benefits from stock-based compensation |
(36 | ) | ||
Deferred income taxes |
135 | |||
Restructuring charges, net |
1 | |||
Equity affiliate income, net |
(21 | ) | ||
Net gain on sales of a business or other assets |
(5 | ) | ||
Other items |
81 | |||
Changes in assets and liabilities that provided (required) cash, net of acquisitions: |
||||
Trade receivables, net |
(310 | ) | ||
Inventory, net |
156 | |||
Deferred revenues |
62 | |||
Accounts payable and other accrued liabilities |
893 | |||
Restructuring cash payments |
(183 | ) | ||
Pension contributions |
(291 | ) | ||
Net investment hedge settlement |
| |||
Other items |
(47 | ) | ||
Net Cash Provided by Operating Activities |
2,814 | |||
Cash Flows Provided (Required) by Investing Activities: |
||||
Purchases of short-term investments |
(732 | ) | ||
Maturities of short-term investments |
430 | |||
Capital expenditures |
(540 | ) | ||
Acquisitions of businesses, net of cash acquired |
(99 | ) | ||
Purchases of long-term equity securities |
| |||
Technology and other investments |
(55 | ) | ||
Other investments and property disposal proceeds |
21 | |||
Net Cash Required by Investing Activities |
(975 | ) | ||
Cash Flows Provided (Required) by Financing Activities: |
||||
Net change in financing with less than 90-day maturities |
69 | |||
Short-term debt proceeds |
84 | |||
Short-term debt reductions |
(74 | ) | ||
Long-term debt proceeds |
299 | |||
Long-term debt reductions |
(193 | ) | ||
Payments on other financing |
(1 | ) | ||
Debt issuance costs |
(5 | ) | ||
Treasury stock purchases |
(502 | ) | ||
Stock option exercises |
65 | |||
Excess tax benefits from stock-based compensation |
36 | |||
Tax withholding on restricted stock and restricted stock units |
(4 | ) | ||
Dividend payments |
(602 | ) | ||
Proceeds from noncontrolling interests |
69 | |||
Dividend payments to noncontrolling interests |
(105 | ) | ||
Net Cash Required by Financing Activities |
(864 | ) | ||
Cash Assumed from Initial Consolidations of Variable Interest Entities |
77 | |||
Effect of Exchange Rate Changes on Cash and Cash Equivalents |
35 | |||
Net Increase in Cash and Cash Equivalents |
1,087 | |||
Cash and Cash Equivalents at Beginning of Period |
1,485 | |||
Cash and Cash Equivalents at End of Period |
$ | 2,572 | ||
Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited
Selected Financial Information
(Dollars in millions)
Unaudited
1. | EBIT, Ongoing EPS and Free Cash Flow: The presentations of EBIT, ongoing EPS and free cash flow are not intended to replace net income (loss) attributable to Monsanto Company, cash flows, financial position or comprehensive income (loss), and they are not measures of financial performance as determined in accordance with generally accepted accounting principles (GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS and free cash flow to the respective most directly comparable financial measure calculated in accordance with GAAP. | |
Reconciliation of EBIT to Net Income (Loss): EBIT is defined as earnings (loss) before interest and taxes. Earnings (loss) is intended to mean net income (loss) attributable to Monsanto Company as presented in the Statements of Consolidated Operations under GAAP. The following table reconciles EBIT to the most directly comparable financial measure, which is net income (loss) attributable to Monsanto. |
Three Months Ended | Twelve Months Ended | |||||||
Aug. 31, 2011 | Aug. 31, 2011 | |||||||
EBIT Seeds and Genomics Segment |
$ | (157 | ) | $ | 2,106 | |||
EBIT Agricultural Productivity Segment |
59 | 281 | ||||||
EBIT Total |
(98 | ) | 2,387 | |||||
Interest Expense, Net |
22 | 88 | ||||||
Income Tax Provision (Benefit)(A) |
(8 | ) | 692 | |||||
Net Income (Loss) Attributable to Monsanto
Company |
$ | (112 | ) | $ | 1,607 | |||
(A) | Includes the income tax provision from continuing operations, the income tax provision (benefit) on noncontrolling interest, and the income tax provision on discontinued operations. |
Reconciliation of EPS to Ongoing EPS: Ongoing EPS is calculated excluding certain after-tax items which Monsanto does not consider part of ongoing operations. |
Fiscal Year | Three Months | Twelve Months | ||||||||||||
2012 | Ended | Ended | ||||||||||||
Guidance | Aug. 31, 2011 | Aug. 31, 2011 | ||||||||||||
Diluted Earnings (Loss) per Share |
$ | 3.34-$3.44 | ($0.21 | ) | $ | 2.96 | ||||||||
Restructuring Charges, Net |
| (0.01 | ) | | ||||||||||
Income on Discontinued Operations |
| | | |||||||||||
Diluted Earnings (Loss) per Share from Ongoing Business |
$ | 3.34-$3.44 | ($0.22 | ) | $ | 2.96 | ||||||||
Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from
operating activities and investing activities, as reflected in the Statements of Consolidated Cash
Flows presented in this release. With respect to the fiscal year 2012 free cash flow guidance,
Monsanto does not include any estimates or projections of Net Cash Provided (Required) by Financing
Activities because in order to prepare any such estimate or projection, Monsanto would need to rely
on market factors and conditions that are outside of its control.
Fiscal Year | Twelve Months Ended | |||||||
2012 | Aug. 31, 2011 | |||||||
Net Cash Provided by Operating Activities |
$ | 2,200-2,500 | $ | 2,814 | ||||
Net Cash Required by Investing Activities |
(900)-(1,000 | ) | (975 | ) | ||||
Free Cash Flow |
$ | 1,300-1,500 | 1,839 | |||||
Net Cash Required by Financing Activities |
N/A | (864 | ) | |||||
Cash Assumed from Initial Consolidations of Variable Interest Entities |
N/A | 77 | ||||||
Effect of Exchange Rate Changes on Cash and Cash Equivalents |
N/A | 35 | ||||||
Net Increase in Cash and Cash Equivalents |
N/A | 1,087 | ||||||
Cash and Cash Equivalents at Beginning of Period |
N/A | 1,485 | ||||||
Cash and Cash Equivalents at End of Period |
N/A | $ | 2,572 |